Company · S.San Francisco, California, United States
Genentech Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 3
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 1
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| LYSATEC RT - PA | 02009285 | Cancelled Post Market | |
| PROTROPIN INJ PWS 10MG/VIAL | 01916742 | Cancelled Post Market | |
| PROTROPIN PWS 5MG/VIAL | 01959263 | Cancelled Post Market |
Notices of Compliance
Newest first.
- PROTROPINDecember 28, 1995 · NOC 5233 · Supplement to a New Drug Submission (SNDS)